1-4 of 4
Douglas Tremblay
Close
Sort by
Journal Articles

CNL and aCML are prognostically distinct: a large National Cancer Database analysis

Douglas Tremblay, Dahniel Sastow, John Mascarenhas
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4400–4402.
https://doi.org/10.1182/bloodadvances.2023010722
Published: 2023
Journal Articles

Pacritinib demonstrates spleen volume reduction in patients with myelofibrosis independent of JAK2V617F allele burden

Clinical Trials & Observations
Douglas Tremblay, Ruben Mesa, Bart Scott, Sarah Buckley, Karisse Roman-Torres, Srdan Verstovsek, John Mascarenhas
Journal: Blood Advances
Blood Adv (2020) 4 (23): 5929–5935.
https://doi.org/10.1182/bloodadvances.2020002970
Published: 2020
Includes: Supplemental data
Journal Articles

The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis

Clinical Trials & Observations
Leonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, Erin Moshier, Kevin Troy, Thomas Schiano, John Mascarenhas
Journal: Blood Advances
Blood Adv (2020) 4 (4): 655–666.
https://doi.org/10.1182/bloodadvances.2019001310
Published: 2020
Journal Articles

Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review

Clinical Trials & Observations
John Y. Rhee, Douglas Tremblay, Amy M. Chan, Martin S. Tallman, John Mascarenhas
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1854–1857.
https://doi.org/10.1182/bloodadvances.2019000249
Published: 2019